Cyclodextrin Polymers as a Promising Drug Carriers for Stabilization of Meropenem Solutions
Source abstract
Abstract
Here we report the development of new drug carriers for meropenem based on the hydroxypropyl-β-cyclodextrin (HPCD) polymers with variable linkers, namely, 1,6-hexamethylenediisocyanate (HMD), citric acid (CA), succinic anhydride (SA). The structures of obtained polyesters and polyurethanes nanoparticles (120–200 nm) were investigated by NMR and FTIR-spectroscopy. The PXRD pattern demonstrated that HPCD polymers form complexes with meropenem (MP), and the majority of MP molecules are encapsulated into a complex. MP’s imprinting in the HPCD-HMD polymer matrix lead to an encapsulation efficiency of up to 82%. HPCD-HMD and HPCD-SA polymers increase MP’s stability during the storage of its aqueous solution (in 1.4 and 1.2 times, respectively). In contrast, HPCD-CA polymer negatively affects MP’s stability. In prospect, the HPCD-HMD polymer may be promising for the development of a highly efficient drug delivery system for MP.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Drug Solubulity and Delivery Systems · Antibiotics Pharmacokinetics and Efficacy · Advanced Drug Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Chemistry Department, Lomonosov Moscow State University, 119991 Moscow, Russia
Funding
Russian Science Foundation
References (37)
Show source-provided references
1. Exposure to WHO AWaRe antibiotics and isolation of multi-drug resistant bacteria: A systematic review and meta-analysis10.1016/j.cmi.2022.03.014 ↗
2. β-Cyclodextrin complexation as an effective drug delivery system for meropenem10.1016/j.ejpb.2015.10.013 ↗
3. PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery10.1016/j.ijpharm.2021.120280 ↗
4. Meropenem: A microbiological overview10.1093/jac/36.suppl_A.1 ↗
5. Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample10.1016/j.jpba.2006.02.017 ↗
6. Cyclodextrins and their uses: A review10.1016/S0032-9592(03)00258-9 ↗
7. Cyclodextrins10.1177/0192623307310945 ↗
8. Cyclodextrins as carriers in targeted delivery of therapeutic agents: Focused review on traditional and inimitable applications10.2174/1381612825666190306163602 ↗
9. Highly soluble cyclodextrin derivatives: Chemistry, properties, and trends in development10.1016/S0169-409X(98)00092-1 ↗
10. Cyclodextrin polymers: Structure, synthesis, and use as drug carriers10.1016/j.progpolymsci.2021.101408 ↗
11. Preparation, characterization and binding behaviors of host-guest inclusion complexes of metoclopramide hydrochloride with α- and β-cyclodextrin molecules10.1016/j.molstruc.2017.11.041 ↗
12. Drug delivery systems for fluoroquinolones: New prospects in tuberculosis treatment10.1134/S1068162017050077 ↗
13. Enzymatic production of cyclodextrins10.1007/s00253-002-1057-x ↗
14. Effect of cross-linking on the inclusion complex formation of derivatized β-cyclodextrins with small-molecule drug moxifloxacin10.1016/j.carres.2020.108183 ↗
15. New versatile approach for analysis of PEG content in conjugates and complexes with biomacromolecules based on FTIR spectroscopy10.1016/j.colsurfb.2016.01.030 ↗
16. Skuredina, A.A., Yu Kopnova, T., Tychinina, A.S., and Golyshev, S.A. (2022). The new strategy for studying drug-delivery systems with prolonged release: Seven-day in vitro antibacterial action. Molecules, 27.10.3390/molecules27228026 ↗
17. Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of L-DOPA: Perspectives for the treatment of Parkinson’s disease10.1080/17425247.2017.1248398 ↗
18. Skuredina, A., Tychinina, A., and Le-Deygen, I. (2022). Cyclodextrins and their polymers affect the lipid membrane permeability and increase levofloxacin’s antibacterial activity in vitro. Polymers, 14.10.3390/polym14214476 ↗
19. Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates10.1007/s11095-010-0073-2 ↗
20. Stability of a 1β-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution10.1248/cpb.43.689 ↗
21. Yang, S.K., Yusoff, K., Mai, C.W., Lim, W.M., Yap, W.S., Lim, S.H., and Lai, K.S. (2017). Additivity vs. synergism: Investigation of the additive interaction of cinnamon bark oil and meropenem in combinatory therapy. Molecules, 22.10.3390/molecules22111733 ↗
22. The formation of quasi-regular polymeric network of cross-linked sulfobutyl ether derivative of β-cyclodextrin synthesized with moxifloxacin as a template10.1016/j.reactfunctpolym.2021.104811 ↗
23. Effect of β-cyclodextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir10.1016/j.jpba.2008.02.006 ↗
24. Water-insoluble β-cyclodextrin polymer crosslinked by citric acid: Synthesis and adsorption properties toward phenol and methylene blue10.1007/s10847-008-9507-4 ↗
25. The effect of citric acid on physicochemical properties of hydrophilic carboxymethyl starch-based films10.1007/s10924-019-01436-9 ↗
26. FTIR investigation of the influence of diisocyanate symmetry on the morphology development in model segmented polyurethanes10.1016/j.polymer.2006.02.027 ↗
27. Suppressing unspecific cell uptake for targeted delivery using hydroxyethyl starch nanocapsules10.1021/bm300653v ↗
28. Vibrational spectra of primary and secondary aliphatic amines10.1063/1.1730168 ↗
29. Solid-state stability study of meropenem - solutions based on spectrophotometric analysis
30. Transparency declarations
31. Development and characterization of meropenem dry powder inhaler formulation for pulmonary drug delivery10.1016/j.ijpharm.2020.119684 ↗
32. Solubility and pseudopolymorphic transitions in mixed solvent: Meropenem in methanol–water solution10.1016/j.fluid.2013.03.028 ↗
33. Dual role of methyl-β-cyclodextrin in the emulsion polymerization of highly hydrophobic plant oil-based monomers with various unsaturations10.1016/j.eurpolymj.2018.09.010 ↗
34. Sala, A., Hoossen, Z., and Bacchi, A. (2021). Two crystal forms of a hydrated 2: 1 β-cyclodextrin fluconazole complex: Single crystal X-ray structures, dehydration profiles, and conditions for their individual. Molecules, 26.10.3390/molecules26154427 ↗
35. Template Conversion of Covalent Organic Frameworks into 2D Conducting Nanocarbons for Catalyzing Oxygen Reduction Reaction10.1002/adma.201706330 ↗
36. Thermal and alkaline stability of meropenem: Degradation products and cytotoxicity10.1016/j.ijpharm.2007.08.023 ↗
37. In vitro stability evaluation of different pharmaceutical products containing meropenem10.1310/hpj5004-296 ↗